Three strains of Rickettsia tsutsugamushi (Karp, Gilliam, and TA716, representing three virulence types in mice) were examined for their sensitivity to the inhibitory effects of recombinant gamma interferon (IFN-'y) and purified IFN-ao/ in two cultured mouse fibroblast cell lines. The susceptibilities of another species, Rickettsia rickettsii, and of encephalomyocarditis virus (EMCV) were also tested for comparative purposes. IFN-'y inhibited rickettsial replication in only one of the six combinations of R. tsutsugamushi strains and mouse cells (strain Gilliam and the BALB/c mouse-derived cell line). In contrast, R. rickettsii and EMCV replication were markedly inhibited in both cell types, but to a greater extent in the BALB/c line than in the C3H cells. IFN-a/i (300 to 450 U/mI) was uniformly ineffective in three of the combinations of R. tsutsugamushi strains and mouse cells (Gilliam in C3H cells and Karp in both C3H and BALB/c cells); in the remaining sets, IFN-a/$-mediated inhibition of rickettsial replication was variable and in no case was it very pronounced. The tests with R. rickettsii in both cell types also indicated slight, variable sensitivity to IFN-ao/$. EMCV, on the other hand, was very susceptible to IFN-.oc, confirming the potency of the preparation used; as with IFN-,y, virus replication was inhibited to a greater degree in the BALB/c cell line than in the C3H cultures. These results are discussed in terms of their relationship to the virulence properties of the R. tsutsugamushi strains in BALB/c and C3H mice and to the known IFN-sensitivities of the more widely studied Rickettsia prowazekii.
Rickettsia tsutsugamushi is an obligately intracellular bacterium which is maintained in nature in trombiculid mites and their rodent hosts and which causes scrub typhus in humans. Several strains have been identified by serological and cross-protection studies, and these antigenic analyses are being refined at the polypeptide and genome levels in a number of laboratories. Scrub typhus rickettsial strains also differ in their virulence for experimental animals, particularly mice. While R. tsutsugamushi does not kill mice infected via the skin (the natural route of infection), a single infectious organism from a virulent strain introduced intraperitoneally is capable of multiplying and ultimately killing a mouse. In contrast, mice can resist 104 to 105 infectious doses of nonvirulent rickettsiae administered by the same route. Although virulence in animal models has been associated with certain serological strains, one study found that different field isolates identified serologically as belonging to the Karp strain were not uniformly virulent in outbred mice (35) . Rickettsia-associated factors which might contribute to virulence are completely unknown. Indeed, little is known about any biological properties which distinguish the scrub typhus rickettsial strains. Recently, one R. tsutsugamushi strain (Karp) was shown to form smaller plaques in mouse cell monolayers than the five other strains with which it was compared, and three strains (Karp, Gilliam, and TA716) were found to replicate at reproducibly different rates in mouse cell cultures (10) .
The virulence of R. tsutsugamushi strains is also dependent on the host, even within a species (7) . Their capacity to establish a lethal infection in mice after intraperitoneal inoculation is governed partially by the presence of the Ric gene on mouse chromosome 5 (and perhaps by other host factors) as well as by properties within the rickettsiae. Mice with the dominant Ricr allele (e.g., BALB/c) survive large intraperitoneal doses of strain Gilliam but not similarly presented Karp rickettsiae (8, 9) . In contrast, mice which are Rics (e.g., C3H/He) are killed equally effectively by low doses of Karp and Gilliam. A third pattern of scrub typhus rickettsial virulence is exemplified by strain TA716, which does not cause fatal disease in mice of either genotype (8) . The C3HRV mouse strain, congenic with C3H/He mice and originally bred for resistance to lethal infections of flaviviruses (1, 6) , was also found to survive infections of R. tsutsugamushi Gilliam, but not Karp, presumably also as a result of the Ricr allele (16, 17) .
Recently, the murine gene Eta-i (early T-lymphocyte activation 1), which maps near or at the Ric locus, has been isolated and characterized (31, 32, 36) . Secreted by activated T lymphocytes, the Eta-i-encoded protein was shown to bind with high affinity to receptors on macrophages and to quickly recruit macrophages and, to a lesser extent, polymorphonuclear cells to the site of intradermal injection (36) .
A T-cell line (Ar5v) which expressed Eta-i even without activation also produced somewhat elevated levels of gamma interferon (IFN--y) mRNA (32) . Within hours after intraperitoneal infection of CBA/CaJ (Ric) mice with R.
tsutsugamushi Gilliam, peritoneal cells contained Eta-i transcripts, and 5 days after infection, these cells contained very few rickettsiae (31) . In contrast, peritoneal cells from similarly infected CBA/J (Rics) mice failed to produce detectable Eta-i mRNA until after the fourth day postinfection and contained large numbers of rickettsiae on the fifth day. Thus, activation of Eta-i in peritoneal cells by R. tsutsugamushi
Gilliam infection appears to be a very early event in the establishment of the resistant state in experimentally infected mice. (This time frame is consistent with earlier studies of genetically related resistance of mice to R. tsutsugamushi Gilliam, which demonstrated differences in the rickettsial content of peritoneal mesothelial cells by 2 days after intraperitoneal inoculation [26] or of peritoneal macrophages and spleen cells as early as 5 days after infection [16, 18] .)
Other host factors which may determine virulence or susceptibility to scrub typhus infection are not understood entirely. Protection of mice from an otherwise lethal inoculation of R. tsutsugamushi has been achieved by transfer of either specific antibody (2, 3, 5, 33, 37) or T lymphocytes (19, 23, 24, 34) , suggesting that both may play a role in recovery from natural infection. The possible involvement of IFN--y and IFN-a/ in recovery from rickettsial infections has been suggested by in vitro and in vivo studies with various Rickettsia species (15, 40) . IFN-y-containing lymphokines, in some cases shown to be a T-cell product(s), have been demonstrated to activate mouse peritoneal macrophages, resulting in a decreased capacity to support growth of R. tsutsugamushi Gilliam (25, [27] [28] [29] [30] . Manifestations of rickettsial clearance were decreased entry of rickettsiae into the treated macrophages, loss of intracellular organisms (27) (28) (29) (30) , and cytolysis specific for treated, infected macrophages (25). Peritoneal macrophages cultured from genetically resistant BALB/c and susceptible C3H/He mice responded equally to lymphokines in their capacity to subsequently limit intracellular Gilliam growth (27) .
Recently I reported the susceptibility of R. tsutsugamushi Gilliam to inhibition by recombinant IFN--y in a BALB/cderived 3T3 continuous mouse fibroblast cell line (13) . The IFN-y treatment had two effects: it was specifically cytotoxic to the Gilliam-infected fibroblasts, and it apparently led to the killing of intracellular rickettsiae. Here, I expand these results by comparing the IFN--y susceptibility of Gilliam to that of two other strains, Karp and TA716, and by using a second cell line, derived from C3H mice, as well as BALB/ 3T3 cells. In addition, the effect of purified IFN-al, in these rickettsia-cell combinations was examined. The results indicate that R. tsutsugamushi susceptibility to rodent interferons is strain dependent and that the cell line used is also important. The availability of scrub typhus rickettsial strains which differ in their sensitivity to IFN-mediated inhibition and of cell lines which differ in their capacity to support IFN-mediated inhibition should provide the means to examine the rickettsial and host cell factors which influence this phenomenon.
MATERIALS AND METHODS
Rickettsiae. Plaque-purified Karp and TA716 strains of R. tsutsugamushi were obtained as yolk sac suspensions from J. V. Osterman and T. R. Jerrells. The Gilliam strain was obtained from C. L. Wisseman, Jr., and plaque purified in our laboratory (10, 13) . All were propagated in embryonated eggs and subsequently in irradiated Vero cells (13 
CO2.
Infection of suspended cells and rickettsial growth curves. The methods of infecting suspended cells and constructing rickettsial growth curves have been described in detail previously (11, 13) . Briefly, cells were removed from monolayers with trypsin, centrifuged, resuspended in TCM, irradiated, and mixed in tubes with rickettsiae which had been appropriately diluted in TCM. After a 1-h absorption period at 37°C, the cells were washed by centrifugation, distributed to 8-chamber tissue culture slides (LabTek Division of Miles Laboratories, Inc., Napierville, Ill.), and incubated at 37°C. At appropriate intervals, slides were stained with Giemsa stain for counting of rickettsiae. At least three sets of 100 cells (each) were counted for each condition.
Plaque assays. The microplaque assay for infectious R. tsutsugamushi and Rickettsia rickettsii has been described previously (12, 13) . All R. tsutsugamushi plaques were counted on day 14 after infection, and R. rickettsii plaques were counted on day 6 after infection. EMCV was plaqued similarly to R. rickettsii (no chicken serum in the overlay medium), but the plaques were visualized by staining methanol-fixed cultures with crystal violet, one day after infection. IFN-a/1 was reconstituted in complete attachment-penetration buffer at pH 7.4 (AP; 11) and stored frozen in aliquots at -80°C; IFN--y was reconstituted and stored as described previously (13) .
IFN assays were performed as described previously (13) . For growth curve assays in chamber slides, cell cultures just reaching confluency in flasks were pretreated with IFN 18 to 20 h before being trypsinized and infected in suspension (as described above). For plaque reduction assays, irradiated cells were seeded into 2-cm2 wells 2 days before infection; the monolayers were treated with IFN the following day, 1 day before plaquing. In plaque reduction experiments, cultures were treated with one to three concentrations of IFN and infected with serial 10-fold dilutions of the infectious agent. The infectious titers (PFU/milliliter) in IFN-treated cultures were compared with those in the corresponding mock-treated cells, and the results are given as percentages of control PFU/milliliter. The statistical significance of the results was determined within each experiment by Student Effect of IFN--y on replication of R. tsutsugamushi Karp in BALB/3T3 cells. In a growth curve type assay in chamber slides, the IFN--y susceptibility of the Karp strain of R. tsutsugamushi was tested in irradiated BALB/3T3 cells which had been treated with 500 IU of IFN-y per ml both 18 h before and immediately after infection (Fig. 1) . Under these conditions, Karp appeared to be completely insensitive to the double treatment with IFN-y, as measured by counting the number of cell-associated rickettsiae (Fig. 1) or by determining the percentage of cells infected (not shown) over a 72-h period. The Karp strain's apparent resistance to IFN--y was in stark contrast to my earlier finding that the replication of strain Gilliam was markedly inhibited by similar treatment with IFN-y in the same cell line (13) . The lack of susceptibility of Karp to IFN--y-mediated inhibition in BALB/3T3 cells was confirmed when the cells were pretreated with a wide range of IFN--y concentrations (Fig. 2) . Karp rickettsiae were not inhibited even by 1,000 IU/ml when either cell-associated rickettsiae per cell at 48 h postinfection or rickettsia-induced cytopathology at 96 h was assessed. Again, this differs from the finding that maximum inhibition of Gilliam replication and cytopathic effect was achieved by similar treatment with as low a dose as 33 IU of IFN-y per ml (13) .
Effect of IFN-y on adhesion of infected cells. A cytotoxic effect of IFN--y pretreatment on Gilliam-infected BALB/3T3 cells has been described previously (13) . This was shown by the-failure of cells which had been pretreated with IFN--y and then infected in suspension with Gilliam to attach to the surface of the chamber slide as well as did untreated, strating the IFN-y-mediated inhibition of Gilliam in BALB/ 3T3 cells (13) . The R. tsutsugamushi strains were tested with 300 to 400 IU of IFN-y per ml, about 10 times the amount needed for maximum inhibition of Gilliam rickettsiae in BALB/3T3 cells. Lower doses were used for R. rickettsii and EMCV when it was found that they were more sensitive to IFN--y (Table 2) . Of the six scrub typhus rickettsial straincell combinations, IFN--y was effective only in Gilliaminfected BALB/3T3 cells: IFN--y treatment did not affect Gilliam replication in C3H cells, nor did it alter the replication of Karp or TA716 in either cell type. To determine whether scrub typhus rickettsiae were unique in their resistance to IFN--y-mediated inhibition in C3H cells, another species, R. rickettsii, and a virus, EMCV, were tested ( Table  2 ). The plaque titers of these infectious agents were reduced to a much greater extent than were those of the scrub typhus rickettsiae; the doses (300 to 400 IU/ml) which inhibited Gilliam plaque formation by about 67% inhibited both R. rickettsii and EMCV by more than 99.9%. This was true in both cell types and in irradiated as well as nonirradiated cultures. Treatment with lower IFN-y concentrations revealed that both R. rickettsii and EMCV were more sensitive to IFN--y in BALB/3T3 cells than in C3H cells: 3 to 10 times more IFN--y was required to effect the same degree of inhibition of these agents in BALB/3T3 cells than in C3H cultures.
Gilliam plaques formed in IFN-y-treated BALB/3T3 cells were no smaller than those in untreated cultures (13 (Fig. 4) . EMCV, as expected, was inhibited by very low concentrations of the IFN-a/I, with 1 IU/ml resulting in 60% inhibition in this experiment. In contrast, a 50% decrease of plaque inhibition of Gilliam in BALB/3T3 cultures was achieved only with IFN-a/P concentrations over 300 IU/ml. Thus, the sensitivity of Gilliam plaque formation to IFN-aI/ was at least 300-fold less than that for EMCV.
Comparative plaque reduction assays were performed with purified mouse IFN-aI/ as had been done with the IFN--y (Table 3 ). For the sake of economy, doses of 300 to 450 IU/ml were used rather than the more strongly inhibitory 1,000 IU/ml (Fig. 4) . Karp in BALB/3T3 and C3H cells and Gilliam in C3H cells always gave negative results. In contrast, the remaining combinations, Gilliam in BALB/3T3 and TA716 in either cell type, were significantly (P < 0.05) inhibited in some experiments but not in others. Likewise, R. rickettsii was slightly inhibited by 300 to 450 IU/ml in half the experiments, but not in the other half. In none of these cases of rickettsial inhibition was the degree of inhibition very great, even with the large doses of IFN-a/,B used. The inconsistencies in these experiments probably reflect the fact that the IFN-a/, concentrations used were at the borderline of the MIC (Fig. 4) . Still, these results do suggest the greater sensitivity of some rickettsial strain-cell line combinations to IFN-a/,B than of others. EMCV, on the other hand, was very a/I (Fig. 4) suggests that more consistent inhibition would have been attained in these experiments with higher IFN-a/, concentrations. The results with R. rickettsii were similar to those with R. tsutsugamushi, in that 300 to 450 IU of IFN-a/,B per ml inhibited plaque formation in only half the experiments, and this was true in both cell types. The marked sensitivity of EMCV to this inhibitor served as a control for the integrity of the IFN-a/, preparations used: as low a dose as 10 IU/ml inhibited EMCV plaque formation consistently in both cell types, and as with IFN--y, the BALB/3T3 cells were more sensitive than the C3H cells.
The mean inhibition by high doses of IFN-a/p of Gilliam in BALB/3T3 cells and of TA716 and R. rickettsii in both cell lines was about 40 to 50%. This is comparable to the maximum inhibition reported by Turco and Winkler for Rickettsia prowazekii in L929 cells treated with IFN-a/p (41) and can be contrasted to the roughly 80% maximum inhibition of Gilliam in BALB/3T3 cells and R. prowazekii in L929 cells by recombinant rodent IFN-y (13, 39, 41 (4) . In light of this and other observations outlined below, the relevance of the greater sensitivity of Gilliam to IFN-ymediated inhibition in the BALB/3T3 cells to the genetically determined resistance of BALB/c mice to this strain is dubious. If there were a definitive correlation between sensitivity to IFN-,y and nonvirulence in mice, then one would expect that TA716 would be inhibited by IFN--y in both cell lines, and the opposite was found. Moreover, treatment of C3HRV and C3H/He macrophage cultures with mouse lymphokines containing IFN--y inhibited Gilliam growth equally (27) , and the lack of a role of IFN-y in the Ric gene-associated resistance to scrub typhus rickettsial infection in mice was also indicated by the failure to detect IFN--y mRNA in peritoneal cells until the fifth or sixth day after intraperitoneal infection of either Rics or Ricr mice with Gilliam, long after the resistant state had been manifested (31) . As far as it goes, all the existing data suggest that IFN--y per se does not play the determining role in R. tsutsugamushi virulence in mice, although they do not preclude the possibility of an accessory or protective role for IFN-y in later stages of primary or secondary infections.
The (8) and in macrophages cultured from BALB/c and C3H/He mice (27) . On the other hand, when long-term replication was assessed, i.e., in the 2-week plaque assays, the plaque titer of Gilliam was sometimes significantly lower and the plaque titer of Karp was sometimes significantly higher in BALB/3T3 cells than in C3H cultures ( Further, if endogenous IFN-ax/, were affecting R. tsutsugamushi plaque formation during the 2-week incubation, this might minimize the effects of any added IFN-a/,. (Note, however, that R. rickettsii plaque assays were incubated for only 6 days.) This question might be clarified by determining whether the addition of antibody to IFN-ot/p increased the plaque titers of scrub typhus rickettsiae (and R. rickettsii) in mouse cultures, as it increased the yields of R. prowazekii in L929 cell cultures (42) . R. tsutsugamushi Karp has been shown to induce an acid-stable IFN-like viral inhibitor in cultured chicken embryo cells (14) .
These studies have shown a remarkable difference between Karp and TA716, on one hand, and Gilliam, on the other, in their sensitivity to IFN-y in the BALB/3T3 cell line. Although differences in the antigens and proteins of these strains are readily demonstrable and although R. tsutsugamushi strains have long been known to differ in their virulence in mice, nothing is understood about the physiological differences among them. The difference in sensitivity to IFN-mediated inhibition reported here is the only biological parameter other than growth rate and plaque size which has been observed. This knowledge should provide a valuable tool for exploring R. tsutsugamushi strain variation at the level of the organisms' interaction with host cells. Such a handle has been missing heretofore. Regardless of the ultimate effect of the mouse Ric gene or of other host components leading to survival of scrub typhus rickettsial infections, the rickettsial factors which contribute to virulence remain an open but intriguing question.
